CompanyGraph
Inspiration Healthcare Group plc
IHC · United Kingdom
inspirationhealthcaregroup.comFinancials as of FY2025 · latest on file
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $22.4M, lower than 95% of all stocks globally
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2025 (year ended January 31, 2025). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
16.59MGBP22.40M · vs all stocks (USD)
Revenue (TTM)
47.55MGBP64.21M · vs all stocks (USD)
Profit Margin
-2.19%vs Medical Devices peers
Beta
0.8720xvs all stocks
52-Week Change
-11.91%vs all stocks
Market Capitalization
16.59MGBP22.40M · vs all stocks (USD)
Enterprise Value
27.18MGBP36.71M · vs all stocks (USD)
Forward P/E
-11.17xvs Medical Devices peers
Price to Sales (TTM)
0.3489xvs Medical Devices peers
Price to Book (MRQ)
1.06xvs Medical Devices peers
Enterprise to Revenue
0.5720xvs Medical Devices peers
Enterprise to EBITDA
13.51xvs Medical Devices peers
Profit Margin
-2.19%vs Medical Devices peers
Operating Margin
2.36%vs Medical Devices peers
Return on Assets (TTM)
1.28%vs Medical Devices peers
Return on Equity (TTM)
-6.44%vs Medical Devices peers
Revenue (TTM)
47.55MGBP64.21M · vs all stocks (USD)
Revenue per Share (TTM)
0.5300GBPUpdated Aug 4, 2026Quarterly Revenue Growth
11.10%vs Medical Devices peers
Gross Profit (TTM)
20.76MGBP28.04M · vs all stocks (USD)
EBITDA (TTM)
2.73MGBP3.68M · vs all stocks (USD)
Net Income (TTM)
-1.04MGBP-1.40M · vs all stocks (USD)
Operating Cash Flow (TTM)
7.54MGBP10.18M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
4.64MGBP6.26M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Operating Cash Flow
-15.69MGBPFY2025 · Jan 31, 2025Free Cash Flow
-16.22MGBPFY2025 · Jan 31, 2025Cash & Cash Equivalents (End of Period)
733.00KGBPFY2025 · Jan 31, 2025Starting Profit (CF Statement)
-14.97MGBPFY2025 · Jan 31, 2025Stock-based Compensation
-115.00KGBPFY2025 · Jan 31, 2025Other Non-cash Items
1.07MGBPFY2025 · Jan 31, 2025Change in Accounts Receivable (CF)
-2.21MGBPFY2025 · Jan 31, 2025Change in Other Assets/Liabilities
533.00KGBPFY2025 · Jan 31, 2025Capital Expenditures
-529.00KGBPFY2025 · Jan 31, 2025Net Intangibles (CF)
-62.00KGBPFY2025 · Jan 31, 2025Net Acquisitions
0.00GBPFY2025 · Jan 31, 2025Sale of Investments
197.00KGBPFY2025 · Jan 31, 2025Net Investing Cash Flow
-332.00KGBPFY2025 · Jan 31, 2025Long-term Debt Issuance
2.98MGBPFY2025 · Jan 31, 2025Long-term Debt Payments
-997.00KGBPFY2025 · Jan 31, 2025Net Short-term Debt Issuance
435.00KGBPFY2025 · Jan 31, 2025Net Financing Cash Flow
5.14MGBPFY2025 · Jan 31, 2025Shares Outstanding
89.66MSharesUpdated Aug 4, 2026Float Shares
40.53MSharesUpdated Aug 4, 2026% Held by Insiders
42.39%vs all stocks
% Held by Institutions
41.51%vs all stocks
Total Cash (MRQ)
1.17MGBP1.58M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0130GBPUpdated Aug 4, 2026Total Debt (MRQ)
11.77MGBP15.89M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7510xvs Medical Devices peers
Current Ratio (MRQ)
1.75xvs Medical Devices peers
Book Value per Share (MRQ)
0.1750GBPUpdated Aug 4, 2026Total Assets
41.08MGBP55.48M · vs all stocks (USD)
Total Current Assets
25.15MGBPFY2025 · Jan 31, 2025Total Liabilities
24.45MGBPFY2025 · Jan 31, 2025Total Non-current Assets
15.93MGBPFY2025 · Jan 31, 2025Total Non-current Liabilities
12.62MGBPFY2025 · Jan 31, 2025Total Current Liabilities
11.83MGBPFY2025 · Jan 31, 2025Cash & Cash Equivalents
733.00KGBPFY2025 · Jan 31, 2025Accounts Receivable
9.35MGBPFY2025 · Jan 31, 2025Inventory
13.08MGBPFY2025 · Jan 31, 2025Accounts Payable
5.66MGBPFY2025 · Jan 31, 2025Short-term Debt
2.63MGBPFY2025 · Jan 31, 2025Long-term Debt
12.35MGBPFY2025 · Jan 31, 2025Common Stock (Book)
8.97MGBPFY2025 · Jan 31, 2025Retained Earnings
4.16MGBPFY2025 · Jan 31, 2025Total Shareholders' Equity
16.64MGBP22.47M · vs all stocks (USD)
52-Week Low
12.30GBXUpdated Aug 4, 202652-Week High
32.00GBXUpdated Aug 4, 202652-Week Change
-11.91%vs all stocks
Beta
0.8720xvs all stocks
50-Day MA
22.28GBXUpdated Aug 4, 2026200-Day MA
21.16GBXUpdated Aug 4, 2026Avg 10-Day Volume
50.27KSharesUpdated Aug 4, 2026Avg 30-Day Volume
49.67KSharesUpdated Aug 4, 2026Diluted EPS (TTM)
-0.0100GBPUpdated Aug 4, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $22.4M, lower than 95% of all stocks globallySignificant
Market cap (USD): 22,402,218.651Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Aptamer Group Plc
Tier 1ProductionApproval-Gated PipelineRule
Rua Life Sciences Plc
Tier 1ProductionApproval-Gated PipelineRule
ImmuPharma PLC
Tier 1ProductionApproval-Gated PipelineRuleRisk
BioLineRx Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Genflow Biosciences Plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
SkinBioTherapeutics Plc
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Cizzle Biotechnology Holdings Plc
Tier 1ProductionApproval-Gated PipelineRule
Crism Therapeutics Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sailong Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Context Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule